Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease.
Rheumatology (Oxford)
; 63(3): 639-647, 2024 Mar 01.
Article
in En
| MEDLINE
| ID: mdl-37294870
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pulmonary Fibrosis
/
Scleroderma, Systemic
/
Lung Diseases, Interstitial
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Rheumatology (Oxford)
Journal subject:
REUMATOLOGIA
Year:
2024
Document type:
Article
Affiliation country:
France
Country of publication:
United kingdom